New company leader brings more than 20 years of experience in top healthcare and medtech roles
SOUTH RIDING, Va., May 18, 2023 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Bret Christensen as President, Chief Executive Officer (CEO), and member of the Board of Directors at DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform.
Christensen comes to DermTech after spending six years as Chief Commercial Officer at Insulet, where he oversaw sales growth from approximately $367 million to $1.1 billion. From August 2013 to May 2017, Christensen served as general manager of Preventive Care at Myriad Genetics, Inc. Previously, Christensen held several executive positions at Hologic, Inc., including vice president of sales and marketing of its Gynecologic Surgical Products division. Prior to Hologic, Christensen led key market development and sales teams at Cytyc Corporation.
"Bret Christensen is a strategic and visionary leader with more than 20 years of successful experience in marketing, sales, and management roles for top genetics testing, healthcare, and medical technology companies," said Leslie Loveless, Slone Partners CEO. "His knowledge and commercial expertise will serve DermTech well as it pushes forward with its business plan to transform dermatology with its revolutionary technology."
Commenting on Christensen's appointment, Matt Posard, DermTech's chairman said, "Bret is well positioned to lead our growing company given his significant commercial, operations, and market access experience. We are confident that Bret's demonstrated success and expertise in the diagnostics industry align with DermTech's strategy to fully capitalize on commercializing its genomic products and executing against its many growth opportunities. The board looks forward to working with Bret and the management team to create meaningful value for stockholders."
Christensen earned a B.S. in business management from Utah Valley University and an MBA from the University of Utah.
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners' value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
ABOUT DERMTECH
DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using our Smart Stickers™. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information, please visit DermTech.
Media Contact
Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected]
SOURCE Slone Partners
Share this article